NextPlat Cuts Operating Expenses by 50% While Revenue Falls 18% to $54M
NextPlat reported $54.3 million in 2025 revenue, an 18% year-over-year decline, with net losses narrowing to $11.7 million (-$0.44/share) while full-year operating expenses fell 50% to $19.9 million. Sequential fourth-quarter margins expanded as 340B contract revenues grew 94% and cost-cutting measures fuel projections for 2026 profitability.
1. Full Year 2025 Financial Results
In 2025 consolidated revenue reached $54.3 million, down 18% from $66.1 million in 2024, driven by lower prescription volumes and 340B contract revenue declines. Net loss narrowed to $11.7 million, or $0.44 per share, versus a $13.4 million loss in the prior year.
2. Margin Expansion and Cost Reductions
Operating expenses declined 50% to $19.9 million following a 20% reduction in salaries and a 49% drop in professional fees, excluding a $13.7 million impairment in 2024. Fourth-quarter margins expanded sequentially as cost-cutting initiatives gained traction.
3. Healthcare Operations Refocus
Prescription volumes fell to 374,000 fills but higher reimbursement rates added $5.1 million in revenue. The company reengaged 340B covered entities, grew contract revenues by 94% sequentially in Q4, and now pursues higher-margin pharmacy contract services.
4. E-commerce Growth and Outlook
E-commerce revenue increased to $14.6 million, up $0.8 million year-over-year, driven by airtime, hardware sales, and a favorable currency impact. Sales records included over 5,000 satellite devices and 12,000 trackers, setting the stage for global connectivity expansion in 2026.